Yasmin Clarke

Experts / Yasmin Clarke

Data analyst; Journalist

Yasmin Clarke is a data analyst & visualisation expert who has provided insights for the NSW Department of Education; the Independent Hospital Pricing Authority; LG Professionals Australia; Roads and Maritime Service (RMS); Transurban; IBM among others. She has a background in science, accounting, and business strategy.

Lagevrio recommended surprisingly often, given recommendations against routine-use

Guidelines say Paxlovid more effective than Lagevrio - yet prescribing rates appear to be similar

Haematology

Clinical Articles

Why aren’t more patients receiving IV iron?

43% of GPs had at least one patient in the last month who wasn’t able to access IV iron they needed

Lagevrio recommended surprisingly often, given recommendations against routine-use

Guidelines say Paxlovid more effective than Lagevrio - yet prescribing rates appear to be similar

By Yasmin Clarke, Lynnette Hoffman

Clinical Articles

Drugs and devices

Why aren’t more patients receiving IV iron?

43% of GPs had at least one patient in the last month who wasn’t able to access IV iron they needed

By Lynnette Hoffman, Yasmin Clarke

Yasmin Clarke

Data analyst; Journalist

More from this expert

Lagevrio recommended surprisingly often, given recommendations against routine-use

Guidelines say Paxlovid more effective than Lagevrio - yet prescribing rates appear to be similar

Why aren’t more patients receiving IV iron?

43% of GPs had at least one patient in the last month who wasn’t able to access IV iron they needed

Lagevrio recommended surprisingly often, given recommendations against routine-use

Guidelines say Paxlovid more effective than Lagevrio - yet prescribing rates appear to be similar

Why aren’t more patients receiving IV iron?

43% of GPs had at least one patient in the last month who wasn’t able to access IV iron they needed

Get the app

Site

Company

Connect

Legal

Discover

Healthed

Yasmin Clarke

Data analyst; Journalist

More from this expert

Lagevrio recommended surprisingly often, given recommendations against routine-use

Guidelines say Paxlovid more effective than Lagevrio - yet prescribing rates appear to be similar

Why aren’t more patients receiving IV iron?

43% of GPs had at least one patient in the last month who wasn’t able to access IV iron they needed

Lagevrio recommended surprisingly often, given recommendations against routine-use

Guidelines say Paxlovid more effective than Lagevrio - yet prescribing rates appear to be similar

Why aren’t more patients receiving IV iron?

43% of GPs had at least one patient in the last month who wasn’t able to access IV iron they needed

Get the app

Site

Company

Connect

Legal

LOG IN FOR FULL ACCESS

SIGN UP FOR A FREE HEALTHED ACCOUNT

Extra Details

PASSWORD RESET

Discover

Healthed